<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="proteomes-01-00219-t001" position="float">
 <object-id pub-id-type="pii">proteomes-01-00219-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Top canonical pathways mapped to common protein changes after exposure to low concentration (100 ng/mL) of SWCNT and MWCNT.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" rowspan="1" colspan="1">Ingenuity Canonical Pathways</th>
    <th align="center" valign="middle" rowspan="1" colspan="1">âˆ’log(
     <italic>p</italic>-value)
    </th>
    <th align="center" valign="middle" rowspan="1" colspan="1">Ratio</th>
    <th align="center" valign="middle" rowspan="1" colspan="1">Molecules</th>
    <th align="center" valign="middle" rowspan="1" colspan="1">Categories</th>
    <th align="center" valign="middle" rowspan="1" colspan="1">Top Functions and Diseases</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Glycogen Degradation III</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">5.07</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">44.40%</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">GAA, PYGB, TYMP, MTAP</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Glycogen Degradation</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">Developmental Disorder; Hereditary Disorder; Metabolic Disease</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Glycogen Degradation II</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">3.63</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">37.50%</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">PYGB, TYMP, MTAP</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Glycogen Degradation</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">Developmental Disorder; Hereditary Disorder; Metabolic Disease</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">RAN Signaling</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">4.07</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">26.70%</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">KPNB1, KPNA2, XPO1, IPO5</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Cellular Growth, Proliferation and Development</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">Cell Signaling; DNA Replication, Recombination, and Repair; Nucleic Acid Metabolism</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Bile Acid Biosynthesis, Neutral Pathway</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">2.15</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">25.00%</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">AKR1C1/AKR1C2, SCP2</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Sterol Biosynthesis</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">Endocrine System Development and Function; Energy Production; Lipid Metabolism</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Methylglyoxal Degradation III</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">2.04</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">22.20%</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">AKR7A2, AKR1C1/AKR1C2</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Aldehyde Degradation</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">Endocrine System Development and Function; Energy Production; Lipid Metabolism</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Telomere Extension by Telomerase</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">2.76</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">20.00%</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">XRCC6, HNRNPA2B1, XRCC5</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Apoptosis; Cancer</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">Cellular Assembly and Organization; Cellular Function and Maintenance; DNA Replication, Recombination, and Repair</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
